| Product Code: ETC13179262 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neglected Tropical Diseases Diagnosis Market was valued at USD 1.7 Billion in 2024 and is expected to reach USD 2.4 Billion by 2031, growing at a compound annual growth rate of 5.30% during the forecast period (2025-2031).
The Global Neglected Tropical Diseases (NTDs) Diagnosis Market is experiencing growth driven by increasing awareness, government initiatives, and partnerships for diagnosis and treatment. NTDs are a group of infectious diseases affecting over a billion people in tropical and subtropical regions. The market includes diagnostic tools such as molecular tests, rapid diagnostic tests (RDTs), and imaging techniques for diseases like malaria, dengue, Chagas disease, and schistosomiasis. Key players in the market are investing in research and development to introduce innovative diagnostic solutions, including point-of-care devices for early and accurate detection of NTDs. The market is also witnessing collaborations between governments, non-profit organizations, and healthcare providers to improve access to diagnostics in underserved regions, driving the market`s expansion.
The Global Neglected Tropical Diseases Diagnosis Market is witnessing a growing demand for improved diagnostics due to increased awareness and government initiatives. Key trends include the development of point-of-care testing solutions for rapid and accurate diagnosis, as well as the adoption of advanced technologies such as molecular diagnostics and imaging techniques. Opportunities in the market lie in expanding access to diagnostics in low-resource settings, collaborating with non-profit organizations and governments to address the burden of neglected tropical diseases, and innovating cost-effective diagnostic solutions. Additionally, the market is seeing a rise in public-private partnerships and collaborations to drive research and development efforts for better diagnostic tools, presenting lucrative opportunities for market players to invest in this underserved segment.
The Global Neglected Tropical Diseases (NTDs) Diagnosis Market faces several challenges, including limited access to diagnostic tools in remote and underserved regions, lack of awareness about NTDs among healthcare providers and communities, and the high cost associated with developing and implementing diagnostic solutions. Additionally, the diverse nature of NTDs, each requiring specific diagnostic tests, complicates the standardization and scalability of diagnostic technologies. Moreover, the inadequate funding for research and development in this field hinders the innovation of accurate and affordable diagnostic tools for NTDs. Overcoming these challenges will require collaboration among governments, non-profit organizations, and private sector stakeholders to prioritize investments in research, improve healthcare infrastructure, and raise awareness about the importance of early and accurate diagnosis of NTDs.
The Global Neglected Tropical Diseases (NTDs) Diagnosis Market is primarily driven by increased awareness and initiatives by governments and non-profit organizations to combat neglected tropical diseases in low-income regions. The rising prevalence of NTDs, coupled with advancements in diagnostic technologies such as rapid diagnostic tests and molecular diagnostics, is also fueling market growth. Additionally, collaborations between pharmaceutical companies, research institutions, and governments to develop innovative diagnostic solutions for NTDs are contributing to market expansion. The growing focus on early detection and treatment of NTDs, along with funding support from international organizations like the World Health Organization and the Bill & Melinda Gates Foundation, further propel the market forward. Overall, a combination of factors including awareness campaigns, technological advancements, and collaborative efforts are key drivers of growth in the Global NTDs Diagnosis Market.
Government policies related to the Global Neglected Tropical Diseases Diagnosis Market typically focus on increasing accessibility to diagnostic tools in low- and middle-income countries, promoting research and development of affordable and accurate diagnostic tests, and supporting public health programs to control and eliminate these diseases. Governments often collaborate with international organizations, non-profits, and private sector partners to improve healthcare infrastructure, strengthen surveillance systems, and enhance capacity building for healthcare professionals. Additionally, initiatives such as the World Health Organization`s Neglected Tropical Diseases roadmap and the United Nations Sustainable Development Goals provide a framework for governments to prioritize funding and resources towards combating these diseases through improved diagnosis and treatment strategies.
The Global Neglected Tropical Diseases Diagnosis Market is expected to witness significant growth in the coming years, driven by increasing awareness and initiatives aimed at tackling these diseases. Factors such as improved healthcare infrastructure in developing countries, technological advancements in diagnostic tools, and rising investments in research and development are expected to fuel market expansion. Additionally, the growing focus on preventive healthcare measures and the implementation of strategic partnerships and collaborations among key market players are likely to contribute to the market`s growth. However, challenges such as limited access to healthcare in remote areas and regulatory hurdles may hinder the market`s progress. Overall, the Global Neglected Tropical Diseases Diagnosis Market is anticipated to show promising growth prospects in the foreseeable future.
In the Global Neglected Tropical Diseases Diagnosis Market, Asia is expected to dominate due to the high burden of diseases such as dengue, malaria, and leishmaniasis. North America and Europe are projected to witness steady growth driven by increasing awareness and government initiatives. The Middle East and Africa region is anticipated to experience significant growth due to rising investments in healthcare infrastructure and initiatives to control diseases like schistosomiasis and Chagas disease. Latin America is also expected to show growth opportunities with a focus on diseases like Chagas disease and leishmaniasis. Overall, the market is poised for growth across all regions, with a focus on improving diagnostic capabilities and access to healthcare services for neglected tropical diseases.
Global Neglected Tropical Diseases Diagnosis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neglected Tropical Diseases Diagnosis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neglected Tropical Diseases Diagnosis Market - Industry Life Cycle |
3.4 Global Neglected Tropical Diseases Diagnosis Market - Porter's Five Forces |
3.5 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.9 Global Neglected Tropical Diseases Diagnosis Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Global Neglected Tropical Diseases Diagnosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neglected Tropical Diseases Diagnosis Market Trends |
6 Global Neglected Tropical Diseases Diagnosis Market, 2021 - 2031 |
6.1 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Dengue, 2021 - 2031 |
6.1.3 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Chikungunya, 2021 - 2031 |
6.1.4 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Rabies, 2021 - 2031 |
6.1.5 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Leprosy, 2021 - 2031 |
6.1.6 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Buruli ulcer, 2021 - 2031 |
6.1.7 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Yaws, 2021 - 2031 |
6.1.8 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Lymphatic Filariasis, 2021 - 2031 |
6.1.9 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Taeniasis/Cysticercosis, 2021 - 2031 |
6.2 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Conventional Method, 2021 - 2031 |
6.2.3 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Molecular/Modern Method, 2021 - 2031 |
6.3 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Centralized Service, 2021 - 2031 |
6.3.3 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By POC Service, 2021 - 2031 |
6.4 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Clinical Labs, 2021 - 2031 |
6.4.3 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Hospitals /Clinics, 2021 - 2031 |
6.4.4 Global Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Home Healthcare, 2021 - 2031 |
7 North America Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
7.1 North America Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.4 North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
7.5 North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.6 North America Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
8 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
8.1 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
8.4 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
8.5 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8.6 Latin America (LATAM) Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
9 Asia Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
9.1 Asia Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
9.4 Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
9.5 Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
9.6 Asia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
10 Africa Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
10.1 Africa Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
10.4 Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
10.5 Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
10.6 Africa Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
11 Europe Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
11.1 Europe Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
11.4 Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
11.5 Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
11.6 Europe Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
12 Middle East Neglected Tropical Diseases Diagnosis Market, Overview & Analysis |
12.1 Middle East Neglected Tropical Diseases Diagnosis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Disease, 2021 - 2031 |
12.4 Middle East Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Method, 2021 - 2031 |
12.5 Middle East Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By Service Type, 2021 - 2031 |
12.6 Middle East Neglected Tropical Diseases Diagnosis Market, Revenues & Volume, By End use, 2021 - 2031 |
13 Global Neglected Tropical Diseases Diagnosis Market Key Performance Indicators |
14 Global Neglected Tropical Diseases Diagnosis Market - Export/Import By Countries Assessment |
15 Global Neglected Tropical Diseases Diagnosis Market - Opportunity Assessment |
15.1 Global Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Disease, 2021 & 2031F |
15.3 Global Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Method, 2021 & 2031F |
15.4 Global Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By Service Type, 2021 & 2031F |
15.5 Global Neglected Tropical Diseases Diagnosis Market Opportunity Assessment, By End use, 2021 & 2031F |
16 Global Neglected Tropical Diseases Diagnosis Market - Competitive Landscape |
16.1 Global Neglected Tropical Diseases Diagnosis Market Revenue Share, By Companies, 2024 |
16.2 Global Neglected Tropical Diseases Diagnosis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |